The Skinny on Diabetes Drugs - a helpful little summary on current treatments from the Motley Fool. Beaker's Blog tells us that only 4 life sciences companies really matter. Who are they, and …
Today’s Top Three in Pharma 012809
Astellas makes a big to acquire CV Therapeutics. Japan's Astellas Pharma is offering a billion dollars in cash for CV Therapeutics. The bid comes in at $16 a share, a whopping 41 percent premium over …